| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | Golgi lumen | 1.73e-05 | 109 | 30 | 4 | GO:0005796 | |
| MousePheno | abnormal hepatic cord morphology | 4.22e-05 | 6 | 24 | 2 | MP:0012246 | |
| MousePheno | increased circulating interferon-gamma level | 9.30e-05 | 52 | 24 | 3 | MP:0008577 | |
| MousePheno | increased interferon level | 2.35e-04 | 71 | 24 | 3 | MP:0014435 | |
| MousePheno | increased susceptibility to infection induced morbidity/mortality | 2.56e-04 | 185 | 24 | 4 | MP:0009787 | |
| MousePheno | abnormal circulating interleukin-1 level | 2.77e-04 | 75 | 24 | 3 | MP:0008589 | |
| MousePheno | increased cytokine level | 2.77e-04 | 75 | 24 | 3 | MP:0014433 | |
| MousePheno | abnormal circulating interferon-gamma level | 3.60e-04 | 82 | 24 | 3 | MP:0008551 | |
| Domain | VWFD | 1.67e-06 | 16 | 28 | 3 | PS51233 | |
| Domain | VWD | 1.67e-06 | 16 | 28 | 3 | SM00216 | |
| Domain | VWF_type-D | 1.67e-06 | 16 | 28 | 3 | IPR001846 | |
| Domain | VWD | 1.67e-06 | 16 | 28 | 3 | PF00094 | |
| Domain | WxxW_domain | 3.24e-05 | 6 | 28 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 3.24e-05 | 6 | 28 | 2 | PF13330 | |
| Domain | - | 4.25e-05 | 663 | 28 | 7 | 2.60.40.10 | |
| Domain | Ig-like_fold | 6.33e-05 | 706 | 28 | 7 | IPR013783 | |
| Domain | TIL | 1.42e-04 | 12 | 28 | 2 | PF01826 | |
| Domain | C8 | 1.42e-04 | 12 | 28 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.67e-04 | 13 | 28 | 2 | IPR014853 | |
| Domain | C8 | 1.67e-04 | 13 | 28 | 2 | SM00832 | |
| Domain | TIL_dom | 1.95e-04 | 14 | 28 | 2 | IPR002919 | |
| Domain | Glyco_hormone_CN | 2.25e-04 | 15 | 28 | 2 | IPR006208 | |
| Domain | Cys_knot | 2.25e-04 | 15 | 28 | 2 | PF00007 | |
| Domain | CTCK_1 | 3.27e-04 | 18 | 28 | 2 | PS01185 | |
| Domain | IG | 3.64e-04 | 421 | 28 | 5 | SM00409 | |
| Domain | Ig_sub | 3.64e-04 | 421 | 28 | 5 | IPR003599 | |
| Domain | VWC_out | 3.65e-04 | 19 | 28 | 2 | SM00215 | |
| Domain | CT | 4.91e-04 | 22 | 28 | 2 | SM00041 | |
| Domain | Cys_knot_C | 6.36e-04 | 25 | 28 | 2 | IPR006207 | |
| Domain | CTCK_2 | 6.36e-04 | 25 | 28 | 2 | PS01225 | |
| Domain | IG_LIKE | 7.33e-04 | 491 | 28 | 5 | PS50835 | |
| Domain | VWC | 8.00e-04 | 28 | 28 | 2 | PF00093 | |
| Domain | Ig-like_dom | 8.17e-04 | 503 | 28 | 5 | IPR007110 | |
| Domain | VWFC_1 | 1.32e-03 | 36 | 28 | 2 | PS01208 | |
| Domain | VWC | 1.47e-03 | 38 | 28 | 2 | SM00214 | |
| Domain | KH_1 | 1.47e-03 | 38 | 28 | 2 | PF00013 | |
| Domain | VWFC_2 | 1.47e-03 | 38 | 28 | 2 | PS50184 | |
| Domain | - | 1.55e-03 | 39 | 28 | 2 | 3.30.1370.10 | |
| Domain | KH | 1.63e-03 | 40 | 28 | 2 | SM00322 | |
| Domain | KH_dom | 1.63e-03 | 40 | 28 | 2 | IPR004087 | |
| Domain | fn3 | 1.79e-03 | 162 | 28 | 3 | PF00041 | |
| Domain | KH_TYPE_1 | 1.80e-03 | 42 | 28 | 2 | PS50084 | |
| Domain | VWF_dom | 1.80e-03 | 42 | 28 | 2 | IPR001007 | |
| Domain | KH_dom_type_1 | 1.97e-03 | 44 | 28 | 2 | IPR004088 | |
| Domain | FN3 | 2.61e-03 | 185 | 28 | 3 | SM00060 | |
| Domain | FN3 | 3.21e-03 | 199 | 28 | 3 | PS50853 | |
| Domain | Ig_V-set | 3.21e-03 | 199 | 28 | 3 | IPR013106 | |
| Domain | FN3_dom | 3.68e-03 | 209 | 28 | 3 | IPR003961 | |
| Domain | IGc2 | 5.11e-03 | 235 | 28 | 3 | SM00408 | |
| Domain | Ig_sub2 | 5.11e-03 | 235 | 28 | 3 | IPR003598 | |
| Domain | ANK_REPEAT | 6.27e-03 | 253 | 28 | 3 | PS50088 | |
| Domain | ANK_REP_REGION | 6.33e-03 | 254 | 28 | 3 | PS50297 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 6.55e-09 | 16 | 21 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 8.55e-09 | 17 | 21 | 4 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.14e-08 | 21 | 21 | 4 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.16e-08 | 23 | 21 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 5.33e-08 | 26 | 21 | 4 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.68e-06 | 60 | 21 | 4 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.92e-06 | 62 | 21 | 4 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.79e-06 | 68 | 21 | 4 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.83e-05 | 109 | 21 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.97e-05 | 111 | 21 | 4 | M27416 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 4.89e-05 | 140 | 21 | 4 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 5.31e-05 | 143 | 21 | 4 | M27275 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 4.56e-04 | 250 | 21 | 4 | M27554 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.36e-09 | 18 | 30 | 4 | 18834073 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 5.78e-09 | 5 | 30 | 3 | 11062147 | |
| Pubmed | 1.16e-08 | 6 | 30 | 3 | 19110483 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 7513696 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20065029 | ||
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 7.19e-07 | 2 | 30 | 2 | 23272068 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 31030254 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20686018 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 7.19e-07 | 2 | 30 | 2 | 27729120 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 34058148 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 37146737 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 7.19e-07 | 2 | 30 | 2 | 23527003 | |
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 7.19e-07 | 2 | 30 | 2 | 14988081 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 16540890 | ||
| Pubmed | PILRα and PILRβ have a siglec fold and provide the basis of binding to sialic acid. | 7.19e-07 | 2 | 30 | 2 | 24843130 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15563276 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 36111525 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 18782111 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24935926 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17621824 | ||
| Pubmed | MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. | 7.19e-07 | 2 | 30 | 2 | 18475301 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 22220206 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24317696 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 7.19e-07 | 2 | 30 | 2 | 27845589 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 22391959 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 14718370 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 7.19e-07 | 2 | 30 | 2 | 35776514 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27435107 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23544943 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24327612 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20573830 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 26871672 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 7.19e-07 | 2 | 30 | 2 | 21653907 | |
| Pubmed | Monocyte infiltration into obese and fibrilized tissues is regulated by PILRα. | 7.19e-07 | 2 | 30 | 2 | 26840635 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 7.19e-07 | 2 | 30 | 2 | 36427316 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 14690056 | ||
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 7.19e-07 | 2 | 30 | 2 | 32348677 | |
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 7.19e-07 | 2 | 30 | 2 | 11587997 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23142774 | ||
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 7.19e-07 | 2 | 30 | 2 | 28607090 | |
| Pubmed | Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice. | 7.19e-07 | 2 | 30 | 2 | 19158956 | |
| Pubmed | Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. | 7.19e-07 | 2 | 30 | 2 | 24722639 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 7.19e-07 | 2 | 30 | 2 | 24332705 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 7.19e-07 | 2 | 30 | 2 | 34656442 | |
| Pubmed | Blood flow guides sequential support of neutrophil arrest and diapedesis by PILR-β1 and PILR-α. | 2.16e-06 | 3 | 30 | 2 | 31385804 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 33232357 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 27776277 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23053434 | ||
| Pubmed | The CD8α-PILRα interaction maintains CD8+ T cell quiescence. | 2.16e-06 | 3 | 30 | 2 | 35617401 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 22479310 | ||
| Pubmed | Autophagy of mucin granules contributes to resolution of airway mucous metaplasia. | 2.16e-06 | 3 | 30 | 2 | 34158522 | |
| Pubmed | Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. | 2.16e-06 | 3 | 30 | 2 | 29604272 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 29286856 | ||
| Pubmed | PANP is a novel O-glycosylated PILRα ligand expressed in neural tissues. | 2.16e-06 | 3 | 30 | 2 | 21241660 | |
| Pubmed | IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells. | 2.16e-06 | 3 | 30 | 2 | 19596978 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 27230679 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 30236127 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 35879412 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 36675209 | ||
| Pubmed | Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium. | 2.16e-06 | 3 | 30 | 2 | 19556605 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23464473 | ||
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 2.16e-06 | 3 | 30 | 2 | 17592322 | |
| Pubmed | Aquaporin 5 expression increases mucin production in lung adenocarcinoma. | 2.16e-06 | 3 | 30 | 2 | 21455588 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 29802623 | ||
| Pubmed | Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue. | 2.16e-06 | 3 | 30 | 2 | 20422702 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 26188512 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 27483328 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 24204560 | ||
| Pubmed | Negative regulation of DSS-induced experimental colitis by PILRα. | 2.16e-06 | 3 | 30 | 2 | 25710489 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 24939955 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 19718741 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 22396535 | ||
| Pubmed | ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites. | 4.31e-06 | 4 | 30 | 2 | 31582416 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 23807779 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 25638393 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 17471237 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 14970179 | ||
| Pubmed | MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium. | 4.31e-06 | 4 | 30 | 2 | 21097527 | |
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 4.31e-06 | 4 | 30 | 2 | 39024979 | |
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 4.31e-06 | 4 | 30 | 2 | 22269464 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 14984930 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 23249391 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 12676567 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 4.31e-06 | 4 | 30 | 2 | 29869461 | |
| Pubmed | Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways. | 4.31e-06 | 4 | 30 | 2 | 18258655 | |
| Pubmed | WNT/RYK signaling restricts goblet cell differentiation during lung development and repair. | 6.50e-06 | 42 | 30 | 3 | 31776260 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 10903717 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 7.18e-06 | 5 | 30 | 2 | 16188033 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 16926269 | ||
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 7.18e-06 | 5 | 30 | 2 | 16475027 | |
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 10660620 | ||
| Pubmed | 2.01e-05 | 8 | 30 | 2 | 27349870 | ||
| Pubmed | 2.01e-05 | 8 | 30 | 2 | 18209065 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.69e-05 | 202 | 30 | 4 | 33005030 | |
| Pubmed | 2.79e-05 | 204 | 30 | 4 | 20503287 | ||
| Pubmed | 2.85e-05 | 205 | 30 | 4 | 19258923 | ||
| Pubmed | 2.96e-05 | 207 | 30 | 4 | 17703412 | ||
| Pubmed | Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. | 3.22e-05 | 10 | 30 | 2 | 18802077 | |
| Pubmed | Epithelial colonization by gut dendritic cells promotes their functional diversification. | 3.22e-05 | 10 | 30 | 2 | 34910930 | |
| Pubmed | 3.94e-05 | 11 | 30 | 2 | 24429156 | ||
| GeneFamily | CD molecules|Mucins | 1.17e-08 | 21 | 23 | 4 | 648 | |
| GeneFamily | Fibronectin type III domain containing | 4.59e-05 | 160 | 23 | 4 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.76e-02 | 161 | 23 | 2 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.81e-02 | 163 | 23 | 2 | 590 | |
| GeneFamily | Immunoglobulin like domain containing | 2.48e-02 | 193 | 23 | 2 | 594 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.08e-05 | 158 | 30 | 4 | MM17063 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.10e-05 | 170 | 30 | 4 | M5880 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b+.SI, CD45+ MHCII+ CD11c-hi CD11b+ CD103+ F4/80-lo, Small Intestine, avg-4 | 6.72e-05 | 58 | 29 | 3 | GSM854237_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103+ F480-, Small Intestine, avg-5 | 1.13e-04 | 69 | 29 | 3 | GSM854232_100 | |
| CoexpressionAtlas | Myeloid Cells, GN.UrAc.PC, CD11b+ Ly6-G+, Peritoneal Cavity, avg-3 | 1.23e-04 | 71 | 29 | 3 | GSM854312_100 | |
| CoexpressionAtlas | BM Top 100 - trachea | 1.28e-04 | 72 | 29 | 3 | BM Top 100 - trachea | |
| CoexpressionAtlas | Myeloid Cells, GN.Thio.PC, CD11b+ Ly6-G+, Peritoneal Cavity, avg-3 | 1.39e-04 | 74 | 29 | 3 | GSM854309_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.SI, CD45+ MHCII+ CD11c-hi CD11b+ CD103- F4/80+, Small Intestine, avg-7 | 1.45e-04 | 75 | 29 | 3 | GSM854262_100 | |
| CoexpressionAtlas | BM Top 100 - bronchus | 1.51e-04 | 76 | 29 | 3 | BM Top 100 - bronchus | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#3_top-relative-expression-ranked_200 | 4.48e-04 | 110 | 29 | 3 | gudmap_kidney_adult_RenalCapsule_k3_200 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-09 | 162 | 30 | 6 | 9c9a63adb692651ea5a52cc77b02c5ce11d0ccea | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-09 | 162 | 30 | 6 | dddf7a3901ae59e3494d8a6740db0fa15cc96d47 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-09 | 162 | 30 | 6 | 1d29983b22f963b34e72cfd1eec328d2d7c4932f | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-09 | 162 | 30 | 6 | 2a4e09545e9874519f0f56e81065104987d81cd6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.87e-08 | 159 | 30 | 5 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-07 | 173 | 30 | 5 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-07 | 188 | 30 | 5 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-07 | 193 | 30 | 5 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-07 | 193 | 30 | 5 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-07 | 194 | 30 | 5 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-07 | 196 | 30 | 5 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-07 | 196 | 30 | 5 | 7a4d502550e9e37dc42f2ff1be3c896afe365d7f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-07 | 196 | 30 | 5 | a52879a4c822c5e4be569f01f845a795e00c5f4b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-07 | 196 | 30 | 5 | 60ea673ed887fe3890c5cf4ff4165384b76d7361 | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.99e-07 | 197 | 30 | 5 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.99e-07 | 197 | 30 | 5 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.99e-07 | 197 | 30 | 5 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.04e-07 | 198 | 30 | 5 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.04e-07 | 198 | 30 | 5 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.04e-07 | 198 | 30 | 5 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.04e-07 | 198 | 30 | 5 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-07 | 199 | 30 | 5 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-07 | 199 | 30 | 5 | 70c0b9cff195d3d24e98443a729e211cac20c90f | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-07 | 199 | 30 | 5 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-07 | 199 | 30 | 5 | ec1e110671e7725f752163c7241dbbf638dec2b2 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5AC+_High|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.10e-07 | 199 | 30 | 5 | a5240868cea40574ed4ee45eb27a00c1812957ed | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-07 | 200 | 30 | 5 | 133853d0f55c63ebe94dd54151f9f1f90650a0d8 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-06 | 155 | 30 | 4 | 62b59cb32b12bd55b19e98786a866d788fc9e4bf | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.33e-06 | 164 | 30 | 4 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.11e-06 | 171 | 30 | 4 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.11e-06 | 171 | 30 | 4 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.47e-06 | 174 | 30 | 4 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.47e-06 | 174 | 30 | 4 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-06 | 175 | 30 | 4 | 8252ddc2ca95071381f0354aefb70c4714828491 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-06 | 175 | 30 | 4 | 8ccf60fc469059d7aaf4e6ce54159db2962e0060 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.99e-06 | 178 | 30 | 4 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.99e-06 | 178 | 30 | 4 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.99e-06 | 178 | 30 | 4 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.99e-06 | 178 | 30 | 4 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.12e-06 | 179 | 30 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 6.12e-06 | 179 | 30 | 4 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.12e-06 | 179 | 30 | 4 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 6.26e-06 | 180 | 30 | 4 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.26e-06 | 180 | 30 | 4 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.26e-06 | 180 | 30 | 4 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.54e-06 | 182 | 30 | 4 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 6.68e-06 | 183 | 30 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 6.68e-06 | 183 | 30 | 4 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 6.83e-06 | 184 | 30 | 4 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.83e-06 | 184 | 30 | 4 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.59e-06 | 189 | 30 | 4 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.75e-06 | 190 | 30 | 4 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 7.75e-06 | 190 | 30 | 4 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.75e-06 | 190 | 30 | 4 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.75e-06 | 190 | 30 | 4 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.91e-06 | 191 | 30 | 4 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.08e-06 | 192 | 30 | 4 | 612be3f861bd2f71a31c57f48c8b10930c3471ea | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.08e-06 | 192 | 30 | 4 | f627a3f43e2340c8ba502211940171f25c7ff436 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.24e-06 | 193 | 30 | 4 | 605fc2a25ed6846fb283b2918cfed98df6039d6b | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 8.24e-06 | 193 | 30 | 4 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-06 | 194 | 30 | 4 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 8.58e-06 | 195 | 30 | 4 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.58e-06 | 195 | 30 | 4 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | Nasal_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.58e-06 | 195 | 30 | 4 | 7509b980b6b293df02bec619ef5b83a6c7b49c03 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.58e-06 | 195 | 30 | 4 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.76e-06 | 196 | 30 | 4 | 808c0a7d1889a8f3508ed9790c6dc7ec16bbc840 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.76e-06 | 196 | 30 | 4 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.76e-06 | 196 | 30 | 4 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.76e-06 | 196 | 30 | 4 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 8.76e-06 | 196 | 30 | 4 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 8.76e-06 | 196 | 30 | 4 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-06 | 196 | 30 | 4 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-06 | 196 | 30 | 4 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.76e-06 | 196 | 30 | 4 | 057d150bdf0cad959fd03ec2d1560a96ba03fae9 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.76e-06 | 196 | 30 | 4 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.76e-06 | 196 | 30 | 4 | b246e482f012dd9782b49c2a953acedfa3c1139d | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.94e-06 | 197 | 30 | 4 | 3f5dfa892a1f631b96eeb6f4cfc284aee51d1ce6 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 8.94e-06 | 197 | 30 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.94e-06 | 197 | 30 | 4 | ff19e4c45715752a04541ad6a0cdf5454c9daaa2 | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.94e-06 | 197 | 30 | 4 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.12e-06 | 198 | 30 | 4 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.12e-06 | 198 | 30 | 4 | 7896f9fb89822e8628fe0b90a489c4760c7b876c | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.12e-06 | 198 | 30 | 4 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.12e-06 | 198 | 30 | 4 | 778fee7020c82d11ff3984a8e482a23e5d58165f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.30e-06 | 199 | 30 | 4 | 1e693d7bb481bf03a943b460a69787229625d7b1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.30e-06 | 199 | 30 | 4 | 73704e8d774b3d08a311f69137972b07015c38f6 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.30e-06 | 199 | 30 | 4 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.30e-06 | 199 | 30 | 4 | 3c3133d0aa65338a576634def13e7f0f5c573a10 | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5B+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.30e-06 | 199 | 30 | 4 | afd0df242a93f176438309668a9487be1250d9ca | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.30e-06 | 199 | 30 | 4 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5AC+_High|Biopsy_IPF / Sample group, Lineage and Cell type | 9.30e-06 | 199 | 30 | 4 | 51cb306e36537a53968c55187bd87c83e1706187 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.30e-06 | 199 | 30 | 4 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.30e-06 | 199 | 30 | 4 | a706ad5cd5e0dc8d7e925a05e45b07d35963f294 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 9.30e-06 | 199 | 30 | 4 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.30e-06 | 199 | 30 | 4 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5B+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.30e-06 | 199 | 30 | 4 | 4ab45996e6bca406c77895a5998982b8ab1cf210 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | 292c63693eb7f435335a8cfba07aa35b72139393 | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5B+|Biopsy_IPF / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | f0a6747f6d37ec6d261bd649ac678c39cca5e4c8 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.49e-06 | 200 | 30 | 4 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 4.05e-06 | 185 | 30 | 5 | 6286_UP | |
| Disease | cholangiocarcinoma (is_marker_for) | 5.59e-09 | 64 | 30 | 5 | DOID:4947 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 4.35e-07 | 61 | 30 | 4 | DOID:3587 (is_marker_for) | |
| Disease | keratoconjunctivitis (is_marker_for) | 3.00e-06 | 3 | 30 | 2 | DOID:9368 (is_marker_for) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 9.97e-06 | 5 | 30 | 2 | DOID:3030 (is_marker_for) | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 2.09e-05 | 7 | 30 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | common bile duct neoplasm (is_marker_for) | 2.79e-05 | 8 | 30 | 2 | DOID:4608 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 4.47e-05 | 10 | 30 | 2 | DOID:10754 (is_marker_for) | |
| Disease | dry eye syndrome (is_marker_for) | 4.47e-05 | 10 | 30 | 2 | DOID:10140 (is_marker_for) | |
| Disease | nucleus accumbens volume change measurement | 5.46e-05 | 11 | 30 | 2 | EFO_0021493 | |
| Disease | pulmonary fibrosis | 5.46e-05 | 11 | 30 | 2 | EFO_0009448 | |
| Disease | otitis media (biomarker_via_orthology) | 1.35e-04 | 17 | 30 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | pancreatic cancer (is_marker_for) | 1.48e-04 | 101 | 30 | 3 | DOID:1793 (is_marker_for) | |
| Disease | Sjogren's syndrome (is_marker_for) | 2.72e-04 | 24 | 30 | 2 | DOID:12894 (is_marker_for) | |
| Disease | lysophosphatidylethanolamine 16:0 measurement | 3.20e-04 | 26 | 30 | 2 | EFO_0010366 | |
| Disease | COVID-19 symptoms measurement | 5.82e-04 | 35 | 30 | 2 | EFO_0600019 | |
| Disease | tuberculosis | 1.36e-03 | 216 | 30 | 3 | MONDO_0018076 | |
| Disease | idiopathic pulmonary fibrosis | 1.54e-03 | 57 | 30 | 2 | EFO_0000768 | |
| Disease | response to opioid | 1.76e-03 | 61 | 30 | 2 | EFO_0008541 | |
| Disease | cystic fibrosis (is_marker_for) | 1.82e-03 | 62 | 30 | 2 | DOID:1485 (is_marker_for) | |
| Disease | interstitial lung disease | 2.12e-03 | 67 | 30 | 2 | EFO_0004244 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.23e-03 | 257 | 30 | 3 | DOID:10652 (is_marker_for) | |
| Disease | urinary bladder cancer (is_implicated_in) | 2.72e-03 | 76 | 30 | 2 | DOID:11054 (is_implicated_in) | |
| Disease | lung adenocarcinoma (is_marker_for) | 3.39e-03 | 85 | 30 | 2 | DOID:3910 (is_marker_for) | |
| Disease | feeling nervous measurement | 3.54e-03 | 87 | 30 | 2 | EFO_0009597 | |
| Disease | Inhalant adrenergic use measurement | 4.29e-03 | 96 | 30 | 2 | EFO_0009941 | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 4.38e-03 | 97 | 30 | 2 | DOID:3083 (is_marker_for) | |
| Disease | susceptibility to pneumonia measurement | 4.38e-03 | 97 | 30 | 2 | EFO_0008410 | |
| Disease | Abortion, Tubal | 5.50e-03 | 109 | 30 | 2 | C0000822 | |
| Disease | Early Pregnancy Loss | 5.50e-03 | 109 | 30 | 2 | C3830362 | |
| Disease | Miscarriage | 5.50e-03 | 109 | 30 | 2 | C4552766 | |
| Disease | Spontaneous abortion | 5.50e-03 | 109 | 30 | 2 | C0000786 | |
| Disease | pancreatic cancer (is_implicated_in) | 5.79e-03 | 112 | 30 | 2 | DOID:1793 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DKTNSLIWTTRTTRT | 976 | Q6ZRH7 | |
| TKVWSLTSSSARTSN | 821 | Q6QNK2 | |
| ATTTTTIGISATWTT | 1536 | O75179 | |
| SSLGTTWTRLSQTTT | 1986 | Q9HC84 | |
| WILTKLTTTATTTES | 3691 | Q9HC84 | |
| TTWILTELTTTATTT | 4246 | Q9HC84 | |
| LRATTSSTSKASSWT | 506 | Q8WXI7 | |
| SQGTLTWDTSITTSQ | 6456 | Q8WXI7 | |
| TTSWRTSIQDTSASS | 181 | Q99102 | |
| TVSTNLTWSSASSLR | 551 | O75325 | |
| TSTTTSKNRIIITWH | 496 | P08069 | |
| TRIASSQTTIWSRST | 426 | Q9H4H8 | |
| SQTTIWSRSTTTQTD | 431 | Q9H4H8 | |
| TQSTSSWQKSRTTTL | 2241 | P98088 | |
| SWQKSRTTTLVTTST | 2246 | P98088 | |
| PTQSTSSWQKSRTTT | 3346 | P98088 | |
| SSWQKSRTTTLVTTS | 3351 | P98088 | |
| QSTSSWQKSRTTTLV | 3646 | P98088 | |
| WQKSRTTTLVTSSIT | 3651 | P98088 | |
| SPTQSTSSWQKSRTT | 4076 | P98088 | |
| TSSWQKSRTTTLVTT | 4081 | P98088 | |
| ISCTTSTTWSRLQTQ | 506 | Q0VG06 | |
| SSSTLTQNEISSVWK | 291 | Q9UMZ3 | |
| KTWQADTSTTLSSIR | 381 | Q460N5 | |
| SSMTTTWRLSSTTTT | 161 | Q9UKJ1 | |
| STVSGTTQSWSSLVK | 1351 | Q9ULT8 | |
| SSWLSTFTTSTSQSL | 626 | Q8NBF6 | |
| EKISWTTKSRTSYSS | 6901 | Q8NDH2 | |
| TSQTSWTSSSTKRNA | 66 | A6NNC1 | |
| TVSKTTSSSITLSWL | 1386 | O60469 | |
| SQVSALSWSQETTKT | 281 | B4DYI2 | |
| INSSITTKAISRWSS | 156 | P49368 | |
| WSSTSSSKIMSQSQV | 666 | P49959 | |
| TLRTTVKEASSTFSW | 336 | P27930 | |
| MSTERTSWTSLSTIQ | 1 | Q9Y2W6 | |
| ASSETSISLIWTKAS | 696 | Q92752 | |
| TRISSAGNTQTTWTT | 421 | Q68DE3 | |
| KLTITQAVTTTTTWR | 146 | Q9UKJ0 | |
| LWSDSSITSVTKSSS | 121 | Q8WYQ9 | |
| VSTSRQTWVATNTLS | 821 | A7E2V4 | |
| SIRSSQWSFSTISSS | 86 | Q9H6X4 | |
| TSTTTIRVWNETVSN | 121 | P57103 |